News
Wednesday, October 24th, 2012
International Diabetes Federation: 10/17/12 There is now extensive evidence on the optimal management of diabetes, offering the opportunity of improving the immediate and long-term quality of life of those with diabetes. Unfortunately such optimal management is not reaching many, perhaps the majority, of the people who could benefit. Reasons include the size and complexity of the […]
News
Wednesday, October 24th, 2012
JAMA: 10/15/12 A Systematic Review and Meta-analysis To compare the prevalence and incidence of type 2 diabetes mellitus between patients with psoriasis and those without psoriasis. Data Sources MEDLINE, EMBASE, and Cochrane Database of Systematic Reviews between January 1, 1980, and January 1, 2012. Study Selection Observational (cohort, case-control, and cross-sectional) studies published in English that […]
News
Wednesday, October 24th, 2012
Informahealthcare: November 11, 2012 Anti-diabetic capacity of Curcuma longa volatile oil in terms of its ability to inhibit glucosidase activities was evaluated. Turmeric volatile oils inhibited glucosidase enzymes more effectively than the reference standard drug acarbose. Drying of rhizomes was found to enhance α-glucosidase (IC50 = 1.32–0.38 μg/ml) and α-amylase (IC50 = 64.7–34.3 μg/ml) inhibitory capacities of volatile oils. Ar-Turmerone, the major volatile component in […]
Minority Diabetes Reports
Wednesday, October 24th, 2012
Informahealthcare: 7/10/12 Diet is an important source of exogenous advanced glycation end products (AGEs). Dietary AGEs content depends on nutrient composition and on the way food is processed/cooked. The objective of our study was to compare AGEs intake of two different ethnic groups (Mexicans and non-Hispanic whites) with type 2 diabetes mellitus (DM) and to […]
Minority Diabetes Reports
Thursday, October 18th, 2012
American Diabetes Association: October 15, 2012 The Diabetes Study of Northern California (DISTANCE) We estimated the prevalence and incidence of diabetes among specific subgroups of Asians and Pacific Islanders (APIs) in a multiethnic U.S. population with uniform access to care. RESEARCH DESIGN AND METHODS This prospective cohort analysis included 2,123,548 adult members of Kaiser Permanente Northern California, […]
Minority Diabetes Reports
Thursday, October 18th, 2012
American Diabetes Association: October 2, 2012 Diabetes prevalence is predicted to rise dramatically during the next 20 years, and associated spending is expected to increase threefold.1–3 Cultural barriers contribute to this burden by preventing optimal care among diverse ethnic groups that are at elevated risk for high-cost complications.4–10 Culturally appropriate, clinically sound, and cost-effective models are needed to […]
Minority Diabetes Reports
Thursday, October 18th, 2012
American Diabetes Association: September 11, 2012 Racial and Ethnic Variations To evaluate racial/ethnic differences in pancreatic triglyceride (TG) levels and their relationship to β-cell dysfunction in humans. RESEARCH DESIGN AND METHODS We studied black, Hispanic, and white adults who completed three research visits: screening and an oral glucose tolerance test; frequently sampled intravenous glucose tolerance tests for […]
Minority Diabetes Reports
Thursday, October 18th, 2012
American Diabetes Association: September 6, 2012 Certain dietary and physical activity behaviors have been associated with the risk of developing type 2 diabetes, yet little is known about the prevalence of these behaviors among Latinas (Latino women). The purpose of this cross-sectional study was to compare the prevalence of diabetes-related behaviors in Latinas and non-Latinas. RESEARCH […]
Minority Diabetes Reports
Thursday, October 18th, 2012
American Diabetes Association: July 1, 2012 Diabetes is a devastating disease that is affected by interdependent genetic, social, economic, cultural, and historic factors. In the United States, nearly 26 million Americans are living with diabetes, and another 79 million Americans have prediabetes.1 This means almost one-third of the total U.S. population is affected by diabetes.2 Diabetes not […]
Clinical Trial News
Thursday, October 18th, 2012
A Randomized, Crossover Study Annals of Internal Medicine: October 16, 2012 Insufficient sleep increases the risk for insulin resistance, type 2 diabetes, and obesity, suggesting that sleep restriction may impair peripheral metabolic pathways. Yet, a direct link between sleep restriction and alterations in molecular metabolic pathways in any peripheral human tissue has not been shown. […]